Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism [PDF]
, 2023 Yijun Song +4 more
openalex +1 more source
Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding [PDF]
, 2023 Kimberly Snow Caroti +13 more
openalex +1 more source
A Comparative Study of the Clinical Benefits of Rivaroxaban and Warfarin in Patients With Non-valvular Atrial Fibrillation With High Bleeding Risk [PDF]
, 2022 Penghui Liu +6 more
openalex +1 more source
Rivaroxaban Treatment for Left Ventricular Thrombus
, 2019 Jayesh Changela, Maria Anwar
openalex +2 more sources
Comparison of the Effects of Injectable Enoxaparin With Oral Rivaroxaban in Deep Vein Thrombotic Prophylaxis in Patients With Femoral Peritrochanteric Fracture: A Randomized Clinical Trial [PDF]
, 2022 Mosayeb Hoseinzadeh +1 more
openalex +1 more source
Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches? [PDF]
, 2014 Al-Khatib, SM +15 more
core +1 more source
Development of a Paediatric Population-Based Model of the Pharmacokinetics of Rivaroxaban [PDF]
, 2013 Stefan Willmann +8 more
openalex +1 more source
Life-Threatening Hemopericardium Associated with Rivaroxaban [PDF]
, 2017 Sijan Basnet +5 more
openalex +1 more source
Post-Pyloric Administration of Rivaroxaban With Therapeutic Monitoring in Pediatric Cardiac Patients: Experience in 3 Patients. [PDF]
J Pediatr Pharmacol TherBranstetter JW +6 more
europepmc +1 more source
Assessment of Pharmacokinetics and Food Effect of AD-109, a Novel Formulation of Rivaroxaban 18 mg. [PDF]
Clin Transl SciRyu H, Cho JY, Lee T, Kim J, Lee S.
europepmc +1 more source